Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in ...
Nuvation Bio Inc. (NYSE: NUVB, Corporate Headquarters: New York, NY, CEO: David Hung, M.D., "Nuvation Bio"), a global ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...
Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the ...
Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.